Search results
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 1 day agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 1 day agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 3 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Pfizer targets $1.5 billion in savings by 2027 as it streamlines operations
WHTC 1450 Holland· 1 day ago(Reuters) -U.S. drugmaker Pfizer said on Wednesday it had launched a multi-year program to reduce...
Pfizer expands cost cuts with new $1.5B target
BioPharma Dive via Yahoo Finance· 2 days agoThe company, which previously announced plans to trim $4 billion in spending by the end of 2024, aims to save another $1.5 billion over the next three...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 11 hours agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 1 day agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
Health care company with Pfizer roots cements position as one of Cincinnati’s fastest-growing firms...
The Business Journals· 4 hours agoHealth care marketing agency Relevate Health is celebrating its success, once again securing a spot...
The Flash May PMI Report Claps Back on Rate Cut Expectations
TheStreet.com· 11 hours agoThe data shows an upturn in the economy with inflation pressures not backing down. * The Flash May...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 13 hours agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...